Results 221 to 230 of about 3,233,658 (249)

Cardiovascular risk and lipid-lowering therapy in idiopathic inflammatory myopathies: a call for improved, disease-specific risk assessment. [PDF]

Rheumatol Adv Pract
Loh K, Rose E, Tansley S.
europepmc   +1 more source

Intra-coronary imaging and transcriptomics of calcified nodules before and after intensive lipid-lowering therapy: a YELLOW III substudy. [PDF]

Eur Heart J Imaging Methods Pract
Revaiah PC, Vengrenyuk Y, Liu J, Yasumura K, Santosh VK, Karki M, Bansal I, Hooda A, Sweeny JK, Khera S, Kapur V, Krishnan P, Moreno PR, Mehran R, Zhou X, Narula J, Sharma SK, Kini AS.   +17 more
europepmc   +1 more source

Echogenicity of carotid plaques as a predictor of regression following lipid-lowering therapy. [PDF]

Thromb J
Fan CH, Hao Y, Chen LF, Cheng J, Wang YQ, Xu LH, Li JM.   +6 more
europepmc   +1 more source

Association of lipid-lowering therapy with dementia and cognitive outcomes: a systematic review and meta-analysis. [PDF]

Age Ageing
Reddin C, Stankard A, Chan KY, Krewer F, Judge C, Canavan M, Davis DHJ, O'Donnell M.   +7 more
europepmc   +1 more source

The Effect of Lipid-Lowering Therapy on Coronary Artery Plaque in East Asia Population. [PDF]

JACC Asia
Fujisaki T, Shirahama Y, Sheng F, Ikeda K, Osada N, Tanaka S, Zhang Y, Tsujita K.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

LDL-C Reduction With Lipid-Lowering Therapy for Primary Prevention of Major Vascular Events Among Older Individuals

Journal of the American College of Cardiology, 2023
Marie Lund, Niklas W. Andersson, Mads Melbye   +2 more
exaly